Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil
A real-world study evaluating tuberculosis incidence in patients with ankylosing spondylitis, psoriatic arthritis, or plaque psoriasis treat…
-
FDA approval · 2024-11-29FDA Approved: YESINTEK — Original Application (Biocon Biologics Inc.)
FDA approved Yesintek (ustekinumab) from Biocon Biologics Inc. under an Original Application. It covers the established ustekinumab indicati…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis [Phase 2]
A Phase 2 clinical trial evaluating ATI-450 versus placebo in adults with moderate to severe psoriatic arthritis was terminated.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Evolution and Treatments of Chronic Inflammatory Systemic Diseases
A recruiting study (NCT04191395) exploring evolution and treatment of chronic inflammatory systemic diseases, including inflammatory bowel d…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab. [Phase 2, Phase 3]
Long-term extension study of tildrakizumab in psoriatic arthritis to evaluate safety in participants who previously completed tildrakizumab …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of SHR-1314 for adults with active psoriatic arthritis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Psoriatic Arthritis Pathobiology and Its Relationship With Clinical Disease Activity
A completed study investigates the pathobiology of psoriatic arthritis and how its biological processes relate to clinical disease activity.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment
A completed real-world evidence study evaluating secukinumab (Cosentyx) in Brazilian patients with psoriasis and psoriatic arthritis. The st…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Efficacy of Pulsed High Intensity Laser Therapy in Psoriatic Hand Arthritis [NA]
A completed clinical trial assessing whether pulsed high-intensity laser therapy improves symptoms in psoriatic hand arthritis.
-
EMA approval · 2024-10-24EMA Authorised: Jylamvo (methotrexate) — Oresund Pharma ApS
The European Medicines Agency authorised Jylamvo, a methotrexate product from Oresund Pharma ApS, for indications including psoriatic arthri…
-
FDA approval · 2024-10-23FDA Approved: JYLAMVO — Supplemental Application (SHORLA ONCOLOGY INC.)
The FDA approved a supplemental application for JYLAMVO (methotrexate) filed by SHORLA ONCOLOGY INC.
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial of bimekizumab for active psoriatic arthritis completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of bimekizumab in active psoriatic arthritis has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Impact of Air Pollution on the Course of Inflammatory Rheumatism [NA]
A clinical trial investigating the impact of air pollution on the course of inflammatory rheumatic diseases, including rheumatoid arthritis,…
-
FDA approval · 2024-10-10FDA Approved: IMULDOSA — Original Application (Accord BioPharma Inc.)
The FDA approves Imuldosa (ustekinumab-srlf) from Accord BioPharma Inc. under an Original Biologics License Application, expanding treatment…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study) [NA]
A completed, multi-center randomized study from Novartis evaluating detection of psoriatic arthritis in Korean patients with moderate-to-sev…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: WORK-ON Vocational Rehabilitation for People with Inflammatory Arthritis [NA]
The WORK-ON Vocational Rehabilitation trial for people with inflammatory arthritis is currently recruiting, sponsored by The Danish Center f…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.
An ongoing clinical trial update evaluating the efficacy of upadacitinib in psoriatic arthritis and comparing its effects to rheumatoid arth…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis [NA]
This clinical trial compares an imaging-guided treat-to-target strategy with a conventional treat-to-target approach in psoriatic arthritis …
-
FDA approval · 2024-09-27FDA Approved: OTULFI — Original Application (Fresenius Kabi USA, LLC)
FDA approved OTULFI (ustekinumab-aauz) from Fresenius Kabi USA, LLC, as an original application. OTULFI is a monoclonal antibody targeting I…
-
FDA approval · 2024-09-26FDA Approved: LEFLUNOMIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Leflunomide submitted by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Stronger Together Psoriatic Arthritis Wellness Study
Updates on a clinical trial for psoriatic arthritis titled 'Stronger Together Psoriatic Arthritis Wellness Study,' currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: AsseSSing Impact in pSoriatic Treatment
University of Oxford-led clinical trial in psoriatic arthritis has completed and posted results on 2024-09-25. The update does not specify a…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database
Completed retrospective cohort study using a claims database to evaluate persistence of biologic therapies in Japanese patients with psoriat…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) [Phase 1]
A Phase 1 clinical trial evaluating certolizumab pegol (Cimzia) in pregnant women with chronic inflammatory diseases has completed and poste…